CLASS II ONGOING Device recall · Reported 22 Jan 2025 · FDA Enforcement Report

DRG:HYBRiD-XL Insulin recalled by DRG International

DRG International is recalling DRG:HYBRiD-XL Insulin, distributed nationwide in the US. The recall was initiated on 7 Oct 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1
Quantity recalled10 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0921-2025
FDA event ID
95785
Recalling firm
DRG International, Springfield, NJ
Classification
Class II
Status
Ongoing
Recall initiated
7 Oct 2024
FDA classified
15 Jan 2025
Reported
22 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

7 Oct 2024Recall initiated by company
15 Jan 2025Classified by FDA+100 days
22 Jan 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Where it was distributed

Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.

Nationwide New Jersey

Questions about this recall

Is DRG:HYBRiD-XL Insulin recalled?

Yes. DRG International recalled DRG:HYBRiD-XL Insulin on 7 Oct 2024. The recall is Class II and its status is Ongoing. Recall number Z-0921-2025.

Why was it recalled?

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Which lots are affected?

UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1

Where was it sold?

Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from DRG International

All 6

Other Other Medical Devices recalls

All 13,778